PMD Solutions

- PMD has not yet established sustainability reporting and targets, which we can expect in 2025
- PMD is not yet profitable
- PMD changed its strategy and international expansion plans long before proving its initial plan as a listed company. As a result, the operational and financial risk is well above average

- PMD operates with high gross margins
- PMD benefits from a high level of recurring revenues
- PMD is addressing very large markets

- PMD has a limited cash position
- PMD is mainly funded by increasing business and sales, hence the ability to grow the business is essential
- The financial risk is also high following the early expansion into the US market

- PMD's ability to grow outside Ireland is still to be proven
- PMD is not yet profitable, and the ability to create value is yet to be fully proven
- PMD changed its strategy and international expansion plans long before proving its initial plan as a listed company.

- PMD has developed RespiraSense, which is well-suited for respiratory  care 
- PMD has a strong vision and well-defined targets
- The founder and the CEO is also the main shareholder